| HS Code | 855604 |
| Product Name | DSM Somos BioClear |
| Manufacturer | DSM Somos (now Covestro) |
| Material Type | Photopolymer resin for stereolithography (SLA) |
| Biocompatibility | Compliant with USP Class VI and ISO 10993-1 |
| Color | Clear/transparent |
| Primary Applications | Medical devices, surgical guides, dental models, hearing aids, and other biocompatible parts |
| Curing Wavelength | 355 nm UV light |
| Viscosity | Approximately 350 cP at 25°C |
| Density | 1.12 g/cm³ liquid; 1.18 g/cm³ cured |
| Hardness | 85 Shore D |
| Tensile Strength | 55 MPa |
| Elongation At Break | 10% |
| Flexural Modulus | 2,500 MPa |
| Glass Transition Temperature | 60°C |
| Sterilization Compatibility | Autoclave, gamma, and ethylene oxide (EtO) |
| Storage Conditions | Store at 18–25°C away from UV light |
| Shelf Life | 12 months |
| Packaging | Supplied in 1 kg and 5 kg containers |
As an accredited DSM Somos BioClear factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive DSM Somos BioClear prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618136850665 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8618136850665
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
DSM Somos BioClear is a clear, low-viscosity stereolithography resin supplied for vat photopolymerization systems operating principally with 355 nm UV laser sources. The material is specified where short-term tissue- or fluid-contact devices require optical transparency combined with biocompatibility screening data rather than the property profile of an inert thermoplastic substitute. Standard builds use 50 µm or 100 µm layer thickness on laser-galvanometer platforms; published processing data for masked DLP or LCD systems is limited because the resin was validated primarily on scanning-laser equipment. The product is sold under the Somos brand with safety data sheets addressing REACH registration and RoHS substance restrictions for the European market, but the material is not presented by the supplier as a food-contact resin. Unpigmented parts are water-clear after post-cure, yet the cured network is glassy and semi-rigid rather than elastomeric, so design rules must account for low elongation and notch sensitivity.
Cured-resin values reported under standard test methods are compiled in Table 1. The tensile response places BioClear in the semi-rigid clear SLA class: tensile strength falls within 45–50 MPa, tensile modulus within 2.2–2.5 GPa, and elongation at break between 6% and 12%. The notched Izod impact range of 25–32 J/m indicates that thin walls, snap-fit features, and sharp internal corners can fail during support removal or service if local stress concentrations exceed the material’s limited plastic deformation capacity. The heat deflection temperature at 0.46 MPa of 46–52 °C defines the upper thermal boundary for load-bearing components; service above this range under mechanical load is outside documented performance. Water absorption at 24 h of 0.30–0.40% is comparatively low for a clear photopolymer network, but dimensional change in humid environments should still be evaluated according to ISO 62:2008 when mating clear components with rigid housings.
| Property | Test method | Reported value |
|---|---|---|
| Tensile strength | ASTM D638-14 | 45–50 MPa |
| Tensile modulus | ASTM D638-14 | 2.2–2.5 GPa |
| Elongation at break | ASTM D638-14 | 6–12% |
| Flexural strength | ASTM D790-17 | 65–75 MPa |
| Flexural modulus | ASTM D790-17 | 2.0–2.3 GPa |
| Notched Izod impact | ASTM D256-10 | 25–32 J/m |
| Hardness | ASTM D2240-15 | 84–86 Shore D |
| Heat deflection temperature at 0.46 MPa | ASTM D648-18 | 46–52 °C |
| Water absorption at 24 h | ASTM D570-98 | 0.30–0.40% |
| Density | ASTM D792-20 | 1.13 g/cm³ |
| Dynamic viscosity at 30 °C | Brookfield LV | 250–350 cP |
The low uncured viscosity of 250–350 cP at 30 °C improves recoat speed on laser-galvanometer stereolithography systems compared with filled biocompatible resins. However, viscosity is temperature-sensitive. In production vats, cooling below 25 °C increases resin layer thickness during recoating and can produce under-cured sidewalls because the wet film is thicker than the intended slice. Conversely, operation above 35 °C accelerates dark polymerization and shortens pot life. Industrial users report that exposure working curves should be re-established when switching resin lots because inhibitor concentration can shift slightly with storage conditions and age, causing batch-to-batch variation in cure depth even when laser power remains stable. A build chamber held at 28–30 °C is typical for maintaining consistent recoating behavior without aggressive thermal aging of the vat.
Post-cured parts are water-clear only after surface finishing; as-built vertical surfaces retain layer striations that scatter light and reduce optical contrast. The supplier does not list a bulk haze value under ASTM D1003-13 because surface roughness dominates the measured scatter in layered stereolithography parts. Low-angle build orientations create stair-step boundaries that require sanding, polishing, or clear-coat application before transmission optics are attempted. Thin transparent windows built at 50 µm layers exhibit lower step height than 100 µm layers, but build time increases nonlinearly because recoating and laser path coverage occupy a larger fraction of the cycle.
Independent evaluations place the cured refractive index near 1.50 at the sodium D line, but published supplier data for refractive index dispersion is limited. When optical modelling is required for lensing or total internal reflection channels, the refractive index should be measured on a post-cured specimen using an Abbe refractometer because cure dose, water uptake, and residual solvent all shift the value. Yellowing is minimal under standard UV post-cure, but thermal post-cure above 80 °C and gamma sterilization above 25 kGy can produce a measurable yellow shift. Optical validation after sterilization is therefore mandatory for clear diagnostic windows or color-sensitive detection paths.
Biocompatibility screening for DSM Somos BioClear is documented under short-term contact classifications. The supplier’s regulatory file references cytotoxicity evaluation per ISO 10993-5:2009, intracutaneous irritation and skin sensitization per ISO 10993-10:2010, and USP Class VI biological reactivity per USP <88>. These data support external communicating devices and limited tissue-contact applications, not permanent implantation. Under ISO 10993-1:2018, the final device manufacturer must complete a biological evaluation for the finished geometry, process history, and sterilization pathway; resin-level certification alone does not confer device-level approval. The material is not characterized for blood-contact circuits, long-term implantation, or drug-delivery reservoirs with prolonged residence time. Table 2 summarizes the compliance scope.
| Assessment | Reference | Scope |
|---|---|---|
| Cytotoxicity | ISO 10993-5:2009 | Supplier file reports pass for L929 fibroblast extracts |
| Irritation | ISO 10993-10:2010 | Intracutaneous reactivity; no greater than control |
| Sensitization | ISO 10993-10:2010 | Guinea pig maximization; no sensitization |
| Systemic injection | USP <88> | Class VI plastics classification |
| Long-term implantation | ISO 10993-1:2018 | Not characterized; device-level evaluation required |
| Sterilization compatibility | ISO 17665-1:2006, ISO 11135:2014, ISO 11137-1:2006 | EO and gamma feasible; steam requires stress-free fixturing |
The resin is not a direct substitute for implantable-grade polymers such as medical PEEK or UHMWPE. Its biocompatibility file is relevant to short-term tissue contact, diagnostic housings, and externally communicating components, but the network contains leachable low-molecular-weight species unless post-processing is controlled. Leachables evaluation under ISO 10993-18:2020 should be performed when the cured part contacts drug-containing fluids, mucosal tissue, or repeated-use skin surfaces. The absence of a long-term implantation qualification is an operational boundary, not a processing defect, and design controls should reflect that boundary.
Steam sterilization at 121 °C standard cycle exceeds the documented heat deflection temperature at 0.46 MPa. Load-bearing features must be fixtured during autoclave to avoid creep, and rapid exhaust should be avoided because pressure differentials can craze thin transparent walls. Validation should follow ISO 17665-1:2006 for moist heat unless the device cannot tolerate the thermal excursion. Because the material absorbs less than 0.40% water at 24 h, moisture-induced expansion is limited but not zero; repeated autoclave cycling can still shift interference fits and optical alignment.
Ethylene oxide processing per ISO 11135:2014 is the common lower-temperature route. ETO is absorbed into the glassy network, and extended aeration at 45–50 °C is required to reduce residual gas below device-specific limits. Gamma irradiation per ISO 11137-1:2006 at 25 kGy typically yellows the part and may increase tensile modulus by additional crosslinking while reducing elongation at break. Post-sterilization mechanical testing per ASTM D638-14 should be performed on specimens from each build orientation because anisotropic layer interfaces can respond differently to radiation-induced crosslinking. Published data for higher gamma doses above 25 kGy is limited, so dose audits should include optical and mechanical acceptance criteria.
Because cure depth follows the Jacobs working curve, reducing layer thickness from 100 µm to 50 µm does not halve the required laser exposure; the relationship is logarithmic and includes a critical exposure threshold. The penetration depth at 355 nm is machine-specific and must be determined by exposure tests on each laser-galvanometer platform. Green-state flexural stiffness at 50 µm is lower in absolute terms, but the finer layer interface reduces mechanical anisotropy and improves sidewall quality in microfluidic channels. Production-scale stereolithography platforms using a recoater blade gap of 0.10–0.15 mm report more stable recoating with BioClear than with highly filled resins, because the low viscosity promotes leveling. However, low temperature operation below 20 °C can produce support delamination and under-cured sidewalls because the photoinitiator response and recoating thickness both shift. The practical process window is bounded by low-temperature viscosity increase and high-temperature dark polymerization rather than by post-cure kinetics alone.
Green-state parts contain unreacted acrylate and methacrylate species that must be removed before skin contact. The supplier-recommended rinsing sequence uses tripropylene glycol monomethyl ether followed by isopropanol; ultrasonic agitation should be limited to short duration because cavitation can initiate microcracks in unsupported thin sections. Ketones, chlorinated solvents, and strongly alkaline cleaners are incompatible and produce surface crazing or stress whitening. After rinsing, parts are dried at 40–50 °C for at least 2 h before UV post-cure to reduce residual solvent retention. The post-cure chamber should emit in the 365–405 nm range and maintain part temperature below 60 °C unless thermal aging is separately validated. Higher post-cure temperatures accelerate conversion but risk yellowing and warp in asymmetric geometries. In high-humidity production environments above 60% RH, desiccant air handling is recommended because residual monomer migration can increase surface tack and interfere with clear-coat adhesion.
The central differentiator is regulatory documentation. General-purpose clear SLA resins may provide similar optical clarity or slightly higher elongation, but they are not supplied with USP Class VI or ISO 10993 biological reactivity screening. Somos WaterShed XC 11122 provides water-resistant clarity for flow models and consumer packaging prototypes, but it is not marketed with a biocompatibility file for medical device body contact. BioClear is therefore selected when the part must enter a design history file under ISO 13485:2016 and requires a resin-level biological evaluation package. The trade-off is thermal and impact performance: BioClear’s heat deflection temperature of 46–52 °C is lower than some engineering SLA grades, and its elongation at break below 12% is less forgiving of snap-fit designs.
Switching from a non-biocompatible clear resin to BioClear requires process changes beyond resin substitution. The photoinitiator package shifts the exposure working curve, and support removal is slightly more prone to fracture because the cured network is optimized for controlled extractables and biological end use rather than maximum toughness. Industrial comparisons show that BioClear recoats faster than filled biocompatible SLA resins due to its lower viscosity, but it produces less green-state stiffness for large overhangs. Published direct comparative mechanical data between BioClear and WaterShed XC 11122 is limited; side-by-side coupons should be printed on the same machine when a replacement qualification is required. The selection should be recorded as a raw-material change under the device manufacturer’s quality system, with re-verification of dimensional accuracy, optical clarity, and biological evaluation according to the finished device risk class.
In microfluidic and short-term diagnostic device fabrication, BioClear is typically built at 50 µm layers to reduce channel wall roughness. Open channels may require solvent polishing with tripropylene glycol monomethyl ether or a clear UV-curable coating to achieve optical access; any coating or adhesive contacting tissue or fluid must be separately assessed under ISO 10993-1:2018. Unpigmented BioClear has been used for optical detection windows because its fluorescence background is lower than pigmented SLA resins, although published excitation-emission matrices for this specific configuration are limited. Flow-path surfaces intended for drug-containing fluids should undergo leachables testing under ISO 10993-18:2020 because the resin network is not inert and residual low-molecular-weight species may migrate under continuous wet contact. Edge-bonded assemblies using ultraviolet-cured adhesives should be validated for burst pressure and channel dimensional stability, since the semi-rigid network can creep at temperatures above 45 °C when pressurized.